Corticosteroid-induced adverse psychiatric effects - Incidence, diagnosis and management

被引:122
作者
Patten, SB [1 ]
Neutel, CI [1 ]
机构
[1] Univ Calgary, Fac Med, Dept Psychiat, Calgary, AB T2N 4N1, Canada
关键词
D O I
10.2165/00002018-200022020-00004
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Reports of corticosteroid-induced adverse psychiatric effects began to appear in the literature soon after the introduction of these medications in the 1950s. Unfortunately, early studies relied on informal classification and measurement procedures and tended to utilise nonspecific descriptive terminology (such as 'steroid psychosis'). A growing number of contemporary investigations have begun to address these problems. However, the literature remains surprisingly undeveloped from a pharmacoepidemiological perspective, consisting largely of case reports and case series. The objective of this review is to summarise published data concerning corticosteroid-induced adverse psychiatric effects. A clinical perspective will be adopted since opportunities to minimise the impact of corticosteroid-induced adverse effects tend to present themselves most readily within the sphere of clinical management. Some of the psychiatric adverse effects of corticosteroids are mild, and not necessarily clinically significant. However, several serious psychiatric syndrome can be caused by corticosteroids: substance-induced mood disorders (with depressive, manic and mixed features), substance-induced psychotic disorders and delirium. While certain clinical groups may be at greater risk of corticosteroid-induced adverse psychiatric effects, corticosteroid-induced psychiatric toxicity is remarkably unpredictable. The literature regarding prevention and treatment of corticosteroid-induced adverse psychiatric effects is poorly developed. As a result, the emphasis of this review is on clinical and epidemiological evidence linking specific adverse effects to corticosteroid medications. However, clinical reports do provide some practical guidance for prevention and treatment, and these are summarised as well. A variety of pharmacological strategies for treatment and prevention have been proposed. Education and support also appear to be important, and perhaps neglected, aspects of management.
引用
收藏
页码:111 / 122
页数:12
相关论文
共 96 条
[11]   CHLORPROMAZINE PROPHYLAXIS OF STEROID-INDUCED PSYCHOSIS [J].
BLOCH, M ;
GUR, E ;
SHALEV, A .
GENERAL HOSPITAL PSYCHIATRY, 1994, 16 (01) :42-44
[12]   SUICIDALITY AND CORTICOSTEROID-INDUCED PSYCHOSIS [J].
BRAUNIG, P ;
BLEISTEIN, J ;
RAO, ML .
BIOLOGICAL PSYCHIATRY, 1989, 26 (02) :209-210
[13]  
Brown E S, 1997, Ann Clin Psychiatry, V9, P185, DOI 10.3109/10401239709147796
[14]   Treatment of corticosteroid-induced mood changes with olanzapine [J].
Brown, ES ;
Khan, DA ;
Suppes, T .
AMERICAN JOURNAL OF PSYCHIATRY, 1999, 156 (06) :968-968
[15]   COMPARISON OF AZATHIOPRINE, PREDNISONE, AND HEPARIN ALONE OR COMBINED IN TREATING LUPUS-NEPHRITIS [J].
CADE, R ;
SPOONER, G ;
SCHLEIN, E ;
PICKERING, M ;
DEQUESADA, A ;
HOLCOMB, A ;
JUNCOS, L ;
RICHARD, G ;
SHIRES, D ;
LEVIN, D ;
HACKETT, R ;
FREE, J ;
HUNT, R ;
FREGLY, M .
NEPHRON, 1973, 10 (01) :37-56
[16]  
CAMERON OG, 1985, INT J PSYCHIAT MED, V15, P213
[17]   PRELIMINARY OBSERVATIONS ON MENTAL DISTURBANCES OCCURRING IN PATIENTS UNDER THERAPY WITH CORTISONE AND ACTH [J].
CLARK, LD ;
BAUER, W ;
COBB, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1952, 246 (06) :205-216
[18]   FURTHER OBSERVATIONS ON MENTAL DISTURBANCES ASSOCIATED WITH CORTISONE AND ACTH THERAPY [J].
CLARK, LD ;
QUARTON, GC ;
COBB, S ;
BAUER, W .
NEW ENGLAND JOURNAL OF MEDICINE, 1953, 249 (05) :178-183
[19]   CUSHINGS-SYNDROME - PSYCHIATRIC-STUDY OF 29 PATIENTS [J].
COHEN, SI .
BRITISH JOURNAL OF PSYCHIATRY, 1980, 136 (FEB) :120-124
[20]   CORTICOSTEROIDS AND PEPTIC-ULCER - METAANALYSIS OF ADVERSE EVENTS DURING STEROID-THERAPY [J].
CONN, HO ;
POYNARD, T .
JOURNAL OF INTERNAL MEDICINE, 1994, 236 (06) :619-632